1
/
of
1
Elabscience
SKU:PKSR030471
Recombinant 2019-nCoV NSP10 Protein (His Tag)
Recombinant 2019-nCoV NSP10 Protein (His Tag)
Regular price
$220.00 USD
Regular price
Sale price
$220.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant 2019-nCoV NSP10 Protein (HIS TAG), a cutting-edge product meticulously engineered to cater to the scientific community's demand for a high-quality protein solution. This protein, derived from the novel coronavirus (2019-nCoV), showcases exceptional purity and functionality, making it an invaluable asset in various research applications.
Crafted with utmost precision, the Recombinant 2019-nCoV NSP10 Protein (HIS TAG) boasts a unique composition that enables researchers to delve into the intricate mechanisms of the 2019-nCoV virus. Its fusion with the HIS TAG epitope further enhances its versatility, facilitating efficient purification and subsequent downstream applications.
This protein exhibits remarkable stability, ensuring consistent and reliable results throughout experimental procedures. Its exceptional solubility in a wide range of buffers and solutions simplifies handling, enabling seamless integration into diverse laboratory protocols.
The Recombinant 2019-nCoV NSP10 Protein (HIS TAG) is meticulously manufactured using state-of-the-art recombinant DNA technology, guaranteeing exceptional quality and reproducibility. Rigorous quality control measures are implemented at every stage of production, ensuring the absence of contaminants and maintaining the protein's integrity.
Researchers can harness the potential of this protein in various applications, including but not limited to protein-protein interaction studies, drug discovery, vaccine development, and diagnostic assay development. Its versatility and reliability make it an indispensable tool for unraveling the intricate workings of the 2019-nCoV virus.
In summary, the Recombinant 2019-nCoV NSP10 Protein (HIS TAG) stands as a pinnacle of scientific innovation, offering researchers an unparalleled opportunity to explore the complexities of the 2019-nCoV virus. With its exceptional purity, stability, and functionality, this protein is poised to revolutionize the field of coronavirus research, paving the way for groundbreaking discoveries and advancements in the fight against this global health threat.
Crafted with utmost precision, the Recombinant 2019-nCoV NSP10 Protein (HIS TAG) boasts a unique composition that enables researchers to delve into the intricate mechanisms of the 2019-nCoV virus. Its fusion with the HIS TAG epitope further enhances its versatility, facilitating efficient purification and subsequent downstream applications.
This protein exhibits remarkable stability, ensuring consistent and reliable results throughout experimental procedures. Its exceptional solubility in a wide range of buffers and solutions simplifies handling, enabling seamless integration into diverse laboratory protocols.
The Recombinant 2019-nCoV NSP10 Protein (HIS TAG) is meticulously manufactured using state-of-the-art recombinant DNA technology, guaranteeing exceptional quality and reproducibility. Rigorous quality control measures are implemented at every stage of production, ensuring the absence of contaminants and maintaining the protein's integrity.
Researchers can harness the potential of this protein in various applications, including but not limited to protein-protein interaction studies, drug discovery, vaccine development, and diagnostic assay development. Its versatility and reliability make it an indispensable tool for unraveling the intricate workings of the 2019-nCoV virus.
In summary, the Recombinant 2019-nCoV NSP10 Protein (HIS TAG) stands as a pinnacle of scientific innovation, offering researchers an unparalleled opportunity to explore the complexities of the 2019-nCoV virus. With its exceptional purity, stability, and functionality, this protein is poised to revolutionize the field of coronavirus research, paving the way for groundbreaking discoveries and advancements in the fight against this global health threat.
Share
